Company Filing History:
Years Active: 2008
Title: Fiona Wai Yu Lau: Innovator in Antidiabetic Compounds
Introduction
Fiona Wai Yu Lau is a prominent inventor based in Edgewater, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target Type 2 diabetes mellitus. Her innovative work has the potential to improve the lives of many individuals suffering from this condition.
Latest Patents
Fiona holds a patent for "Antidiabetic bicyclic compounds." This patent describes tricyclic compounds containing a cyclopropyl carboxylic acid or carboxylic acid derivative, such as an amide, fused to a bicyclic ring. These compounds, including pharmaceutically acceptable salts and prodrugs, act as agonists of G-protein coupled receptor 40 (GPR40). They are particularly useful as therapeutic agents in treating Type 2 diabetes and associated conditions, including obesity and lipid disorders.
Career Highlights
Fiona is currently employed at Merck & Company, Inc., where she continues to advance her research in the pharmaceutical industry. Her work is characterized by a commitment to innovation and a focus on developing effective treatments for chronic diseases.
Collaborations
Fiona collaborates with talented colleagues, including Min Ge and Jiafang He. These partnerships enhance her research efforts and contribute to the development of groundbreaking therapeutic solutions.
Conclusion
Fiona Wai Yu Lau is a dedicated inventor whose work in antidiabetic compounds showcases her commitment to improving healthcare outcomes. Her innovative contributions are paving the way for new treatments that can significantly impact the lives of those affected by diabetes and related conditions.